ING exits Asian equities

The exclusive due diligence agreement includes operations in 10 Asian countries – Hong Kong, Korea, Japan, Taiwan, Thailand, Singapore, China, Indonesia, Malaysia and the Philippines, as well as ING’s Asian sales and trading desks in London and Asian sales desk in New York. The bank will continue to offer equity derivatives, mergers and acquisitions advisory, debt capital markets and fixed-income products, foreign exchange and treasury, structured finance and syndicated loans to clients in 12 countries in Asia.

“What we wanted to do is actually concentrate our business on servicing a select group of corporate clients, governments, financial institutions, and then cross-sell to them a range of what we call value-added products,” says an ING official in Hong Kong.

However, some market participants believe that the planned sale could impact its equity derivatives business, which ING began building up in Asia in 2002 with the hiring of former Goldman Sachs banker Trinh Du to head up a new Hong Kong-based structured and listed equity derivatives trading division. At the time, ING said the equity derivatives business would leverage off its equity franchise and banking and insurance networks in the region.

“If they lose the cash side of things they are probably losing distribution. They are losing the ability to have dialogue with the kind of people who could be buying their products,” says one head of equity derivatives in Hong Kong. “For Macquarie it makes sense because the bank has been a strong player in warrants and they understand derivatives reasonably well. This gives them a cash presence and allows them to expand.”

The move marks the latest small or mid-sized player to exit the cash equities market, following Indosuez WI Carr in 2001 and French bank SG in 2002.

The ING official said that the price of ING’s cash equities business is “very much dependant on the due diligence”. Both banks plan to make a further announcement before March 31.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here